Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N & Williams JK (2002) The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arteriosclerosis, Thrombosis and Vascular Biology 22, 1859–1864.
Adlercreutz H, Fotsis T, Bannwart C, Wahala K, Makela T, Brunow G & Hase T (1986) Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. Journal of Steroid Biochemistry 25, 791–797.
Adlercreutz H, Fotsis T, Setchell K & Axelson M (1981) Effect of diet and antibiotics on urinary-excretion of lignans. Journal of Clinical Chemistry and Clinical Biochemistry 19, 597.
Adlercreutz H & Mazur W (1997) Phyto-oestrogens and Western diseases. Annals of Medicine 29, 95–120.
Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592–5595.
Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW & Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. American Journal of Clinical Nutrition 72, 844–852.
An JP, Tzagarakis-Foster C, Scharschmidt TC, Lomri N & Leitman DC (2001) Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. Journal of Biological Chemistry 276, 17808–17814.
Anderson JJ, Chen X, Boass A, Symons M, Kohlmeier M, Renner JB & Garner SC (2002) Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. Journal of the American College of Nutrition 21, 388–393.
Anderson JJ & Garner SC (1998) Phytoestrogens and bone. Baillieres Clinical Endocrinology and Metabolism 12, 543–557.
Anderson JW, Diwadkar VA & Bridges SR (1998) Selective effects of different antioxidants on oxidation of lipoproteins from rats. Proceedings of the Society for Experimental Biology and Medicine 218, 376–381.
Anderson JW, Johnstone BM & Cooknewell ME (1995) Metaanalysis of the effects of soy protein-intake on serum-lipids. New England Journal of Medicine 333, 276–282.
Anthony MS, Clarkson TB, Hughes CL Jr Morgan TM & Burke GL (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. Journal of Nutrition 126, 43–50.
Arjmandi BH (2001) The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. Journal of the American College of Nutrition 20, 398S–402S.
Arora A, Nair MG & Strasburg GM (1998) Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Archives of Biochemistry and, Biophysics 356, 133–141.
Atkinson C, Compston JE, Day NE, Dowsett M & Bingham SA (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition 79, 326–333.
Atkinson C, Frankenfeld CL & Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Experimetal Biology and Medicine 230, 155–170.
Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM & Setchell KDR (1982) The identification of the weak estrogen equol 7-hydroxy-3-(4'- hydroxyphenyl)chroman in human-urine. Biochemical Journal 201, 353–357.
Axelson M, Sjovall J, Gustafsson BE & Setchell KDR (1984) Soya – a dietary source of the non-steroidal estrogen equol in man and animals. Journal of Endocrinology 102, 49–56.
Banks E, Beral V, Bull D, Reeves G, Austoker J, English R, Patnick J, Peto R, Vessey M, Wallis M, Abbott S & Bailey E, et al. (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419–427.
Bannwart C, Fotsis T, Heikkinen R & Adlercreutz H (1984) Identification of the isoflavonic phytoestrogen daidzein in human urine. Clinica Chimica Acta 136, 165–172.
Barnes S (1998) Phytoestrogens and breast cancer. Baillieres Clinical Endocrinology and Metabolism 12, 559–579.
Barnes S, Kim H, Darley-Usmar V, Patel R, Xu J, Boersma B & Luo M (2000) Beyond ERalpha and ERbeta: estrogen receptor binding is only part of the isoflavone story. Journal of Nutrition 130, 656S–657S.
Baum JA, Teng HY, Erdman JW, Weigel RM, Klein BP, Persky VW, Freels S, Surya P, Bakhit RM, Ramos E, Shay NF & Potter SM (1998) Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American Journal of Clinical Nutrition 68, 545–551.
Beecher GR, Bhagwat S, Holden JM, Haytowitz D & Murphy PA (1999) Isoflavone database for foods. FASEB Journal 13, A885.
Bennetts H, Underwood E & Shier F (1946) A specific breeding problem of sheep in subterranean clover pastures in Western Australia. Australian Veterinary Journal 22, 2–12.
Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA & Zeisel SH (2002) Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. American Journal of Clinical Nutrition 76, 1126–1137.
Blum A, Lang N, Vigder F, Israeli P, Gumanovsky M, Lupovitz S, Elgazi A, Peleg A & Moshe BA (2003) Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clinical and Investigative Medicine – Medecine Clinique et Experimentale 26, 20–26.
Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P & Laurent S (2002) Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients – a longitudinal study. Hypertension 39, 10–15.
Branca F (2003) Dietary phyto-oestrogens and bone health. Proceedings of the Nutrition Society 62, 877–887.
Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, Wong E & Thompson LU (2004) Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. American Journal of Clinical Nutrition 79, 318–325.
Cassidy A (2003) Potential risks and benefits of phytoestrogen-rich diets. International Journal for Vitamin and Nutritional Research 73, 120–126.
Cassidy A (1996) Physiological effects of phyto-oestrogens in relation to cancer and other human health risks. Proceedings of the Nutrition Society 55, 399–417.
Cassidy A, Bingham S & Setchell K (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. British Journal of Nutrition 74, 587–601.
Cassidy A, Bingham S & Setchell KD (1994) Biological effects of a diet of soya protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333–340.
Cassidy A & Faughnan M (2000) Phyto-oestrogens through the life cycle. Proceedings of the Nutrition Society 59, 489–496.
Cassidy A & Griffin B (1999) Phyto-oestrogens: a potential role in the prevention of CHD? Proceedings of the Nutrition Society 58, 193–199.
Chang HC, Churchwell MI, Delclos KB, Newbold RR & Doerge DR (2000) Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. Journal of Nutrition 130, 1963–1970.
Chen XW, Garner SC, Quarles LD & Anderson JJB (2003) Effects of genistein on expression cell of bone markers during MC3T3-E1 osteoblastic differentiation. Journal of Nutritional Biochemistry 14, 342–349.
Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F & Franke AA (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutrition and Cancer 33, 82–87.
Chiechi LM, Secreto G, Vimercati A, Greco P, Venturelli E, Pansini F, Fanelli M, Loizzi P & Selvaggi L (2002) The effects of a soy rich diet on serum lipids: the Menfis randomized trial. Maturitas 41, 97–104.
Clemons M & Goss P (2001) Mechanisms of disease – estrogen and the risk of breast cancer. New England Journal of Medicine 344, 276–285.
Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML & Moreton T (2001) The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8, 259–265.
Couse JF, Lindzey J, Grandien K, Gustafsson JA & Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha- knockout mouse. Endocrinology 138, 4613–4621.
Coward L, Barnes NC, Setchell KDR & Barnes S (1993) Genistein, daidzein, and their beta-glycoside conjugates – antitumor isoflavones in soybean foods from American and Asian diets. Journal of Agricultural and Food Chemistry 41, 1961–1967.
Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M & Burke GL (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives of Internal Medicine 159, 2070–2076.
Cuevas AM, Irribarra VL, Castillo OA, Yanez MD & Germain A (2003) Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women. European Journal of Clinical Nutrition 57, 889–894.
Cummings SR, Cauley JA, Palermo L, Ross PD, Wasnich RD, Black D & Faulkner KG (1994) Racial-differences in hip axis lengths might explain racial-differences in rates of hip fracture. Osteoporosis International 4, 226–229.
Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R & Strauss BJ (1998) Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1, 124–129.
D'Amico G & Gentile MG (1993) Influence of diet on lipid abnormalities in human renal disease. American Journal of Kidney Diseases 22, 151–157.
Davis JN, Kucuk O, Djuric Z & Sarkar FH (2001) Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radical Biology and Medicine 30, 1293–1302.
Demonty I, Lamarche B & Jones PJ (2003) Role of isoflavones in the hypocholesterolemic effect of soy. Nutrition Reviews 61, 189–203.
Dewell A, Hollenbeck CB & Bruce B (2002) The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. Journal of Clinical Endocrinology and Metabolism 87, 118–121.
Djuric Z, Chen G, Doerge DR, Heilbrun LK & Kucuk O (2001) Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Letters 172, 1–6.
Doerge DR, Churchwell MI, Chang HC, Newbold RR & Delclos KB (2001) Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague Dawley rats. Reproductive Toxicology 15, 105–110.
Duffy R, Wiseman H & File SE (2003) Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacology, Biochemistry and Behavior 75, 721–729.
Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR & Kurzer MS (1999) Soy isoflavones exert modest hormonal effects in premenopausal women. Journal of Clinical Endocrinology and Metabolism 84, 192–197.
Duncan AM, Merz-Demlow BE, Xu X, Phipps WR & Kurzer MS (2000) Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 9, 581–586.
Fanti P, Sawaya BP, Custer LJ & Franke AA (1999) Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients. Journal of the American Society of Nephrology 10, 864–871.
Fanti P, Stephenson TJ, Kaariainen IM, Rezkalla B, Tsukamoto Y, Morishita T, Nomura M, Kitiyakara C, Custer LJ & Franke AA (2003) Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis. Nephrology Dialysis Transplantation 18, 1862–1868.
Faughnan MS, Hawdon A, Ah-Singh E, Brown J, Millward DJ & Cassidy A (2004) Urinary isoflavone kinetics: the effect of age, gender, food matrix and chemical composition. British Journal of Nutrition 91, 567–574.
File SE, Jarrett N, Fluck E, Duffy R, Casey K & Wiseman H (2001) Eating soya improves human memory. Psychopharmacology 157, 430–436.
Fleming R (2003) What effect, if any, does soy protein have on breast tissue? Integrative Cancer Therapies 2, 225–228.
Foth D & Cline JM (1998) Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. American Journal of Clinical Nutrition 68, 1413S–1417S.
Frankenfeld CL, Atkinson C, Thomas WK, Goode EL, Gonzalez A, Jokela T, Wahala K, Schwartz SM, Li SS & Lampe JW (2004) Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Advances in Experimental Medicine and Biology 229, 902–913.
Gallagher JC, Satpathy R, Rafferty K & Haynatzka V (2004) The effect of soy protein isolate on bone metabolism. Menopause – the Journal of the North American Menopause Society 11, 290–298.
Gooderham MH, Adlercreutz H, Ojala ST, Wahala K & Holub BJ (1996) A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. Journal of Nutrition 126, 2000–2006.
Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH & Kolonel LN (1997) Association of soy and fiber consumption with the risk of endometrial cancer. American Journal of Epidemiology 146, 294–306.
Guo TL, White KL Jr, Brown RD, Delclos KB, Newbold RR, Weis C, Germolec DR & McCay JA (2002 a) Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicology and Applied Pharmacology 181, 219–227.
Guo TL, Zhang XL, Bartolucci E, McCay JA, White KL Jr & You L (2002 b) Genistein and methoxychlor modulate the activity of natural killer cells and the expression of phenotypic markers by thymocytes and splenocytes in F0 and F1 generations of Sprague-Dawley rats. Toxicology 172, 205–215.
Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR & Quyyumi AA (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653–658.
Hale G, Paul-Labrador M, Dwyer JH & Merz CN (2002) Isoflavone supplementation and endothelial function in menopausal women. Clinical Endocrinology 56, 693–701.
Hale GE, Hughes CL, Robboy SJ, Agarwal SK & Bievre M (2001) A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 8, 338–346.
Heikaus S, Winterhager E, Traub O & Grummer R (2002) Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens. Journal of Molecular Endocrinology 29, 239–249.
Hermansen K, Dinesen B, Hoie LH, Morgenstern E & Gruenwald J (2003) Effects of soy and other natural products on LDL: HDL ratio and other lipid parameters: a literature review. Advances in Therapy 20, 50–78.
Hermansen K, Sondergaard M, Hoie L, Carstensen M & Brock B (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24, 228–233.
Hill CE & Dye L (2003) Phytoestrogens and cognitive performance: a review of the evidence. Current Topics in Nutraceutical Research 1, 203–212.
Ho SC (1996) Body measurements, bone mass, and fractures – does the East differ from the West? Clinical Orthopaedics and Related Research 323, 75–80.
Hodgson JM, Croft KD, Puddey IB, Mori TA & Beilin LJ (1996) Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. Journal of Nutritional Biochemistry 7, 664–669.
Hodgson JM, Puddey IB, Croft KD, Mori TA, Rivera J & Beilin LJ (1999) Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure. Atherosclerosis 145, 167–172.
Honore EK, Williams JK, Anthony MS & Clarkson TB (1997) Soya isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertility and Sterility 67, 148–154.
Horn-Ross PL, John EM, Canchola AJ, Stewart SL & Lee MM (2003) Phytoestrogen intake and endometrial cancer risk. Journal of the National Cancer Institute 95, 1158–1164.
Howes JB, Tran D, Brillante D & Howes LG (2003) Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes, Obesity and Metabolism 5, 325–332.
Hsu CS, Shen WW, Hsueh YM & Yeh SL (2001) Soya isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. Journal of Reproductive Medicine 46, 221–226.
Hutchins AM, Lampe JW, Martini MC, Campbell DR & Slavin JL (1995) Vegetables, fruits, and legumes: effect on urinary isoflavonoid phytoestrogen and lignan excretion. Journal of American Dietetic Association 95, 769–774.
Ibrahim AR & Abulhajj YJ (1990) Aromatase inhibition by flavonoids. Journal of Steroid Biochemistry and Molecular Biology 37, 257–260.
Izumi T, Piskula MK, Osawa S, Obata H, Tobe K, Saito M, Kataoka S, Kubota Y & Kikuchi M (2000) Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. Journal of Nutrition 130, 1695–1699.
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP & Yu MC (2002) Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiology, Biomarkers and Prevention 11, 608–613.
Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA & Atkin SL (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25, 1709–1714.
Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner D & Vidgen E (2002) Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism: Clinical and Experimental 51, 919–924.
Joannou GE, Kelly GE, Reeder AY, Waring M & Nelson C (1995) A urinary profile study of dietary phytoestrogens – the identification and mode of metabolism of new isoflavonoids. Journal of Steroid Biochemistry and Molecular Biology 54, 167–184.
Kang HJ, Ansbacher R & Hammoud MM (2002) Use of alternative and complementary medicine in menopause. International Journal of Gynaecology and Obstetrics 79, 195–207.
Kao YC, Zhou C, Sherman M, Laughton CA & Chen S (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environmental Health Perspectives 106, 85–92.
Kelly GE, Nelson C, Waring MA, Joannou GE & Reeder AY (1993) Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta 223, 9–22.
Kim H, Peterson TG & Barnes S (1998) Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. American Journal of Clinical Nutrition 68, 1418S–1425S.
Kirkman LM, Lampe JW, Campbell DR, Martini MC & Slavin JL (1995) Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutrition and Cancer 24, 1–12.
Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EHF, Aleman A, Lampe JW, van der Schouw YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292, 65–74.
Kritz-Silverstein D, von Muhlen, D Barrett-Connor|E & Bressel MA (2003) Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) study. Menopause 10, 196–202.
Kronenberg F & Fugh-Berman A (2002) Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Annals of Internal Medicine 137, 805–813.
Kuiper G, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863–870.
Kuiper G, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT van der Burg P Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263.
Lafferty HM & Brenner BM (1990) Are glomerular hypertension and hypertrophy independent risk-factors for progression of renal-disease. Seminars in Nephrology 10, 294–304.
Lamartiniere CA (2002) Timing of exposure and mammary cancer risk. Journal of Mammary Gland Biology and Neoplasia 7, 67–76.
Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ & Barnes S (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis 16, 2833–2840.
Lampe JW, Karr SC, Hutchins AM & Slavin JL (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proceedings of the Society for Experimental Biology and Medicine 217, 335–339.
Latonnelle K, Le Menn F, Kaushik SJ & Bennetau-Pelissero C (2002) Effects of dietary phytoestrogens in vivo and in vitro in rainbow trout and Siberian sturgeon: interests and limits of the in vitro studies of interspecies differences. General and Comparative Endocrinology 126, 39–51.
Lavigne C, Marette A & Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. American Journal of Physiology 278, E491–E500.
Le Lain R, Nicholls PJ, Smith HJ & Maharlouie FH (2001) Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer. Journal of Enzyme Inhibition 16, 35–45.
Lephart ED, West TW, Weber KS, Rhees RW, Setchell KD, Adlercreutz H & Lund TD (2002) Neuro behavioral effects of dietary soy phytoestrogens. Neurotoxicology and Teratology 24, 5–16.
Lu LJ, Anderson KE, Grady JJ & Nagamani M (2002) Chronic soy consumption influences serum levels of steroid and peptide hormones without uterine effects in postmenopausal women. Journal of Nutrition 132, 615S.
Lu LJ & Anderson KE (1998) Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. American Journal of Clinical Nutrition 68, 1500S–1504S.
Lund TD, West TW, Tian LY, Bu LH, Simmons DL, Setchell KD, Adlercreutz H & Lephart ED (2001) Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neuroscience 2, 20.
Lundh T (1995) Metabolism of estrogenic isoflavones in domestic-animals. Proceedings of the Society for Experimental Biology and Medicine 208, 33–39.
Lydeking-Olsen E, Beck-Jensen JE, Setchell KD & Holm-Jensen T (2004) Soymilk or progesterone for prevention of bone loss – a 2 year randomized, placebo-controlled trial. European Journal of Nutrition 43, 246–257.
McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS & Bundred NJ (1998) Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68, 1431S–1436S.
McPherson K (2004) Where are we now with hormone replacement therapy? It works for symptoms but is not good for future health. BMJ 328, 357–358.
Maddox DA, Alavi FK, Silbernick EM & Zawada ET (2002) Protective effects of a soy diet in preventing obesity-linked renal disease. Kidney International 61, 96–104.
Makela S, Poutanen M, Kostlan ML, Lehtimaki N, Strauss L, Santti R & Vihko R (1998) Inhibition of 17 beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proceedings of the Society for Experimental Biology and Medicine 217, 310–316.
Markiewicz L, Garey J, Adlercreutz H & Gurpide E (1993) Invitro bioassays of nonsteroidal phytoestrogens. Journal of Steroid Biochemistry and Molecular Biology 45, 399–405.
Maskarinec GF, Williams AE & Carlin L (2003) Mammographic densities in a one-year isoflavone intervention. European Journal of Cancer Prevention 12, 165–169.
Messina M & Hughes C (2003) Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. Journal of Medicinal Food 6, 1–11.
Messina MJ & Loprinzi CL (2001) Soy for breast cancer survivors: a critical review of the literature. Journal of Nutrition 131, 3095S–3108S.
Miodini P, Fioravanti L, Di Fronzo G & Cappelletti V (1999) The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. British Journal of Cancer 80, 1150–1155.
Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR & Duthie GG (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Archives of Biochemistry and Biophysics 360, 142–148.
Montano MM & Katzenellenbogen BS (1997) The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proceedings of the National Academy of Sciences of the USA 94, 2581–2586.
Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R & Squadrito F (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. Journal of Bone and Mineral Research 17, 1904–1912.
Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG & Adlercreutz H (2003) Soy isoflavones: a safety review. Nutrition Reviews 61, 1–33.
Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG & Morton MS (1995) Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 21, 189–195.
Murphy PA, Song T, Buseman G, Barua K, Beecher GR, Trainer D & Holden J (1999) Isoflavones in retail and institutional soy foods. Journal of Agricultural and Food Chemistry 47, 2697–2704.
Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE & Fritz MA (2003) Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause 10, 456–464.
Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N & Yasuda K (1999) Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric 2, 6–12.
Nagata C, Takatsuka N, Kawakami N & Shimizu H (2001) Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. American Journal of Epidemiology 153, 790–793.
Nagata C, Takatsuka N, Kurisu Y & Shimizu H (1998) Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. Journal of Nutrition 128, 209–213.
Nagel SC, vom Saal FS & Welshons WV (1998) The|effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proceedings of the Society for Experimental Biology and Medicine 217, 300–309.
Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD & West L (1999) Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. Journal of Clinical Endocrinology and Metabolism 84, 895–898.
Nilsson S, Kuiper G & Gustafsson JA (1998) ER beta: a novel estrogen receptor offers the potential for new drug development. Trends in Endocrinology and Metabolism 9, 387–395.
Pansini F, Bonaccorsi G & Albertazzi P (1997) Soy phytoestrogens and bone. Proceedings of the North American Menopause Society 44
Peeters PHM, Keinan-Boker L, van der, Schouw YT & Grobbee DE (2003) Phytoestrogens and breast cancer risk – review of the epidemiological evidence. Breast Cancer Research and Treatment 77, 171–183.
Penotti M, Fabio E, Modena AB, Rinaldi M, Omedei U & Vigano P (2003) Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility 79, 1112–1117.
Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, Miike R, Kirk M & Coward L (1996) Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology Biomarkers and Prevention 5, 785–794.
Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JK & Carlquist M (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO Journal 18, 4608–4618.
Pinnell SR (2003) Cutaneous photodamage, oxidative stress, and topical antioxidant protection. Journal of the American Academy of Dermatology 48, 1–22.
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. American Journal of Clinical Nutrition 68, 1375S–1379S.
Powles T (2004) Isoflavones and women's health. Breast Cancer Research 6, 140–142.
Ranich T, Bhathena SJ & Velasquez MT (2001) Protective effects of dietary phytoestrogens in chronic renal disease. Journal of Renal Nutrition 11, 183–193.
Register TC & Adams MR (1998) Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. Journal of Steroid Biochemistry and Molecular Biology 64, 187–191.
Rimbach G, Weinberg PD, de Pascual-Teresa S, Alonso MG, Ewins BA, Turner R, Minihane AM, Botting N, Fairley B, Matsugo S, Uchida Y & Cassidy A (2004) Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochimica et Biophysica Acta 1670, 229–237.
Rivas M, Garay RP, Escanero JF, Cia P & Alda JO (2002) Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. Journal of Nutrition 132, 1900–1902.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Kotchen M & Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women – principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321–333.
Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G & Cassidy A (2003) Bioavailability of phyto-oestrogens. British Journal of Nutrition 89, S45–S58.
Rowland I, Wiseman H, Sanders T, Adlercreutz H & Bowey E (1999) Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochemical Society Transactions 27, 304–308.
Rowland IR, Wiseman H, Sanders TA, Adlercreutz H & Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutrition and Cancer 36, 27–32.
Rubanyi GM, Kauser K & Johns A (2002) Role of estrogen receptors in the vascular system. Vascular Pharmacology 38, 81–88.
Sader MA & Celermajer DS (2002) Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovascular Research 53, 597–604.
Samman S, Lyons Wall PM, Chan GS, Smith SJ & Petocz P (1999) The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277–283.
Sathyamoorthy N, Gilsdorf JS & Wang TT (1998) Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Anticancer Research 18, 2449–2453.
Scambia G, Mango D, Signorile PG, Angeli RA, Palena C, Gallo D, Bombardelli E, Morazzoni P, Riva A & Mancuso S (2000) Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause – the Journal of the North American Menopause Society 7, 105–111.
Schaffer P (1997) Epidemiology of cervical and endometrial cancer. Bulletin De L'Academie Nationale De Medecine 181, 1347–1364.
Scheiber MD, Liu JH, Subbiah MTR, Rebar RW & Setchell KDR (2001) Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause – the Journal of the North American Menopause Society 8, 384–392.
Secreto G, Chiechi LM, Amadori A, Miceli R, Venturelli E, Valerio T & Marubini E (2004) Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 47, 11–20.
Seow A, Shi CY, Franke AA, Hankin JH, Lee HP & Yu MC (1998) Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiology Biomarkers and Prevention 7, 135–140.
Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A & Heubi JE (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition 131, 1362S–1375S.
Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V & Heubi JE (2003 a) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. Journal of Nutrition 133, 1027–1035.
Setchell KD, Brown NM & Lydeking-Olsen E (2002 a) The clinical, importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 132, 3577–3584.
Setchell KD & Cole SJ (2003) Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. Journal of Agricultural and Food Chemistry 51, 4146–4155.
Setchell KD, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, Wolfe BE, Brashear WT, Desai P, Oldfield MF, Botting NP & Cassidy A (2003 b) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. American Journal of Clinical Nutrition 77, 411–419.
Setchell KD & Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. American Journal of Clinical Nutrition 78, 593S–609S.
Setchell KD, Zimmer-Nechemias L, Cai J & Heubi JE (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350, 23–27.
Setchell KDR (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition 68, 1333S–1346S.
Setchell KDR, Borriello SP, Hulme P, Kirk DN & Axelson M (1984) Nonsteroidal estrogens of dietary origin – possible roles in hormone-dependent disease. American Journal of Clinical Nutrition 40, 569–578.
Setchell KDR, Brown NM & Lydeking-Olsen E (2002 b) The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition 132, 3577–3584.
Setchell KDR & Cassidy A (1999) Dietary isoflavones: biological effects and relevance to human health. Journal of Nutrition 129, 758S–767S.
Shu XO, Brinton LA, Zheng W, Gao YT, Fan J & Fraumeni JF (1991) A population-based case-control study of endometrial cancer in Shanghai, China. International Journal of Cancer 49, 38–43.
Shutt DA & Cox RI (1972) Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. Journal of Endocrinology 52, 299–310.
Shyong EQ, Lu Y, Lazinsky A, Saladi RN, Phelps RG, Austin LM, Lebwohl M & Wei H (2002) Effects of the isoflavone 4',5,7-trihydroxyisoflavone, (genistein) on psoralen plus ultraviolet A radiation, (PUVA)-induced photodamage. Carcinogenesis 23, 317–321.
Simons LA, von Konigsmark M, Simons J & Celermajer DS (2000) Phyto-oestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. American Journal of Cardiology 85, 1297–1301.
Solanky KS, Bailey NJC, Beckwith-Hall BM, Davis A, Bingham S, Holmes E, Nicholson JK & Cassidy A (2003) Application of biofluid H-1 nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Analytical Biochemistry 323, 197–204.
Somekawa Y, Chiguchi M, Ishibashi T & Aso T (2001) Soya intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology 97, 109–115.
Steinberg FM, Guthrie NL, Villablanca AC, Kumar K & Murray MJ (2003) Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. American Journal of Clinical Nutrition 78, 123–130.
Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 86, 3053–3060.
Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A & Nestel PJ (2003) Isoflavones reduce arterial stiffness – a placebo-controlled study in men and postmenopausal women. Arteriosclerosis Thrombosis and Vascular Biology 23, 1066–1071.
Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T & Cummings SR (2003) Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract, (ICE) Study: a randomized controlled trial. JAMA 290, 207–214.
Tobias JH, Cook DG, Chambers TJ & Dalzell N (1994) A comparison of bone-mineral density between Caucasian, Asian and Afro-Caribbean Women. Clinical Science 87, 587–591.
Turner R, Baron T, Wolffram S, Minihane AM, Cassidy A, Rimbach G & Weinberg PD (2004) Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radical Research 38, 209–216.
Uesugi T, Fukui Y & Yamori Y (2002) Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study. Journal of the American College of Nutrition 21, 97–102.
Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL & Lamia CA (2000) Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 7, 236–242.
van Popele NM, Grobbee DE, Bots ML, Asman R, Topouchian J, Reneman RS, Hoeks APG, van der Kuip DAM, Hofman A & Witteman JCM (2001) Association between arterial stiffness and atherosclerosis – The Rotterdam study. Stroke 32, 454–460.
Velasquez MT & Bhathena SJ (2001) Dietary phytoestrogens: a possible role in renal disease protection. American Journal of Kidney Diseases 37, 1056–1068.
Vigna GB, Pansini F, Bonaccorsi G, Albertazzi P, Donega P, Zanotti L, De Aloysio D, Mollica G & Fellin R (2000) Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. Nutrition Metabolism and Cardiovascular Diseases 10, 315–322.
Wade MG, Lee A, McMahon A, Cooke G & Curran I (2003) The influence of dietary isoflavone on the uterotrophic response in juvenile rats. Food and Chemical Toxicology 41, 1517–1525.
Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L & Clarkson TB (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism – Clinical and Experimental 46, 698–705.
Wahala K & Alho S (2002) Soy isoflavones and binding sites of estrogen receptor alpha and beta and 17 beta-hydroxysteroid dehydrogenase type 1 enzyme. Journal of Nutrition 132, 591S–592S.
Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y, Nakayama T, Wada M & Ohno Y (1999) Dietary intake and sources of isoflavones among Japanese. Nutrition and Cancer 33, 139–145.
Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR & Kurzer MS (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 85, 3043–3048.
Washburn S, Burke GL, Morgan T & Anthony M (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause – the Journal of the North American Menopause Society 6, 7–13.
Watanabe T, Akishita M, Nakaoka T, Kozaki K, Miyahara Y, He H, Ohike Y, Ogita T, Inoue S, Muramatsu M, Yamashita N & Ouchi Y (2003) Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation. Cardiovascular Research 59, 734–744.
Weggemans RM & Trautwein EA (2003) Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. European Journal of Clinical Nutrition 57, 940–946.
Wei H, Saladi R, Lu Y, Wang Y, Palep SR, Moore J, Phelps R, Shyong E & Lebwohl MG (2003) Isoflavone genistein: photoprotection and clinical implications in dermatology. Journal of Nutrition 133, 3811S–3819S.
Wei H, Wei L, Frenkel K, Bowen R & Barnes S (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutrition and Cancer 20, 1–12.
Wei H, Zhang X, Wang Y & Lebwohl M (2002) Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Letters 185, 21–29.
White L, Petrovitch H, Ross W, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C & Curb JD (1996) Prevalence of dementia in older Japanese-American men in Hawaii – The Honolulu-Asia Aging Study. JAMA 276, 955–960.
Williams JK & Clarkson TB (1998) Dietary soy isoflavones inhibit in-vivo constrictor responses of coronary arteries to collagen-induced platelet activation. Coronary Artery Disease 9, 759–764.
Wong WW (2000) Effects of soy isoflavone on blood lipids, blood pressure, and biochemical markers of bone metabolism in postmenopausal women. Journal of Nutrition 130, 686S.
Xu WH, Zheng W, Xiang YB, Ruan ZM, Cheng JR, Dai Q, Gao YT & Shu XO (2004) Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study. BMJ 328, 1285–1288.
Xu X, Duncan AM, Merz BE & Kurzer MS (1998) Effects of soya isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiology, Biomarkers and Prevention 7, 1101–1108.
Xu X, Wang HJ, Murphy PA, Cook L & Hendrich S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. Journal of Nutrition 124, 825–832.
Yamamoto S, Sobue T, Kobayashi M, Sasaki S & Tsugane S (2003) Soy, isoflavones, and breast cancer risk in Japan. Journal of the National Cancer Institute 95, 906–913.
Yildirir A, Tokgozoglu SL, Oduncu T, Oto A, Haznedaroglu I, Akinci D, Koksal G, Sade E, Kirazli S & Kes S (2001) Soy protein diet significantly improves endothelial function and lipid parameters. Clinical Cardiology 24, 711–716.
Yoles I, Yogev Y, Frenkel Y, Nahum R, Hirsch M & Kaplan B (2003) Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss. Menopause 10, 522–525.
Zava DT, Blen M & Duwe G (1997) Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environmental Health Perspectives 105, 637–645.
Zubik L & Meydani M (2003) Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. American Journal of Clinical Nutrition 77, 1459–1465.